SHILPAMED

HealthcareDrug Manufacturers - Specialty & GenericMid Cap
Shilpa Medicare Limited

Shilpa Medicare Limited, a healthcare company in the Drug Manufacturers - Specialty & Generic sub-sector, manufactures and sells active pharmaceutical ingredients (APIs), finished ...

हिन्दी में

शिल्पा मेडिकेयर लिमिटेड, ड्रग मैन्युफैक्चरर्स - स्पेशलिटी एंड जेनेरिक उप-क्षेत्र में एक हेल्थकेयर कंपनी है, जो एक्टिव फार्मास्युटिकल इंग्रीडिएंट्स (APIs), फिनिश्ड डोसेज फॉर्मूलेशन ...

₹1,071.2-0.23%1D
Previous trading day close · Data updates after market close
1W: +2.3%
1M: +14.0%
6M: +155.7%
1Y: +178.3%
56/100
AverageResearch Score
Market Cap
₹11.2K Cr
Mid Cap
P/E Ratio
75.70
Premium
P/B Ratio
8.09
Premium
ROE
3.8%
Weak
ROCE
12.0%
Average
Debt / Equity
0.25
Low debt
Div. Yield
0.1%
EV/EBITDA
45.45
Expensive
52W Low: ₹259.5Current: ₹1,071.252W High: ₹1,095
At 97% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
62/100
Growth
Revenue, EPS, profit growth
60/100
Valuation
PE, PB, EV/EBITDA vs sector
34/100
Risk
Debt levels, volatility, coverage
74/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
75.70(Premium)
Forward P/E
51.35(Premium)
P/B Ratio
8.09(Premium)
P/S Ratio
12.45(Expensive)
EV/EBITDA
45.45(Expensive)
Dividend Yield
0.1%
5Y CAGR
16.9%(High growth)
Revenue Growth
44.9%(High)
Profitability
ROE
3.8%(Average)
ROCE
12.0%(Average)
ROA
2.4%(Average)
Net Margin
17.7%(High)
EBITDA Margin
30.0%
Financial Health
Debt to Equity
0.25(Low debt)
Current Ratio
1.46(Tight)
Quick Ratio
0.95(Tight)
Interest Coverage
7.34x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
69(Neutral)
RSI Exp (14)
59(Neutral)
MACD
50.790(Bullish)
MACD Signal
53.349
BB Position
80%(Upper band)
BB Width
20.60%(High volatility)
ADX (14)
24.4(Weak trend)
Williams %R
-13.8(Overbought)
MFI (14)
77(Neutral)
CCI (20)
95(Neutral)
Stoch %K
86(Overbought)
ATR (14)
51.56(Avg True Range)
OBV (M)
135.7(Positive)
1W OBV Chg
0.3%(Increasing)
Rel Volume
0.27x(Low activity)
Volatility
44.3%(High)
Max DD 1Y
-45.8%(High loss)
Alpha (CAPM)
161.01%(Outperforming Nifty)
Return vs Nifty
171.7%(Beating Nifty)
EMA 200
627.3
EMA 50
899.4
SMA 200
535.5
vs SMA 50
21.1%(Above SMA50)
vs SMA 200
100.0%(Above SMA200)
Volume
4.33L
Avg Vol 3M
16.2L
Shareholding Pattern
Promoter
40.1%
Moderate
FII
11.1%
DII / MF
8.6%
Share SHILPAMED
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.